N

NuCana plc
D

NCNA

1.56000
USD
-0.02
(-1.27%)
Market Closed
Volume
838
EPS
0
Div Yield
0
P/E
-0
Market Cap
3,504,384
OverviewSignalsIdeasNews
Related Instruments
    AMGN
    2.78
    (0.84%)
    295.935 USD
    B
    BIIB
    -2.500
    (-1.17%)
    210.710 USD
    C
    CRSP
    -2.450
    (-4.28%)
    54.840 USD
    E
    EDIT
    -0.28500
    (-5.26%)
    5.13500 USD
    GILD
    0.470
    (0.62%)
    76.510 USD
    I
    ILMN
    -0.250
    (-0.20%)
    122.370 USD
    I
    INCY
    -0.680
    (-1.05%)
    64.390 USD
    MRNA
    -25.020
    (-20.99%)
    94.160 USD
    REGN
    13.14
    (1.22%)
    1,091.19 USD
    VRTX
    9.75
    (1.97%)
    484.2 USD
    More
News

Title: NuCana plc

Sector: Healthcare
Industry: Biotechnology
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.